Gilead Sciences, Inc. (GILD)
147.10
+0.25
(+0.17%)
USD |
NASDAQ |
Oct 08, 16:00
147.06
-0.04
(-0.03%)
After-Hours: 20:00
Gilead Sciences 30-Day Average Daily Volume : 5.591M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 5.591M |
| October 07, 2026 | 5.616M |
| October 06, 2026 | 5.601M |
| October 05, 2026 | 5.683M |
| October 02, 2026 | 5.658M |
| October 01, 2026 | 5.729M |
| September 30, 2026 | 5.805M |
| September 29, 2026 | 5.819M |
| September 28, 2026 | 5.773M |
| September 25, 2026 | 5.717M |
| September 24, 2026 | 5.704M |
| September 23, 2026 | 5.724M |
| September 22, 2026 | 5.701M |
| September 21, 2026 | 5.759M |
| September 18, 2026 | 5.847M |
| September 17, 2026 | 5.607M |
| September 16, 2026 | 5.725M |
| September 15, 2026 | 5.889M |
| September 14, 2026 | 5.988M |
| September 11, 2026 | 6.042M |
| September 10, 2026 | 6.126M |
| September 09, 2026 | 6.184M |
| September 08, 2026 | 6.263M |
| September 04, 2026 | 6.226M |
| September 03, 2026 | 6.204M |
| Date | Value |
|---|---|
| September 02, 2026 | 6.264M |
| September 01, 2026 | 6.259M |
| August 31, 2026 | 6.375M |
| August 28, 2026 | 6.292M |
| August 27, 2026 | 6.391M |
| August 26, 2026 | 6.488M |
| August 25, 2026 | 6.461M |
| August 24, 2026 | 6.482M |
| August 21, 2026 | 6.447M |
| August 20, 2026 | 6.466M |
| August 19, 2026 | 6.421M |
| August 18, 2026 | 6.478M |
| August 17, 2026 | 6.592M |
| August 14, 2026 | 6.819M |
| August 13, 2026 | 6.975M |
| August 12, 2026 | 7.033M |
| August 11, 2026 | 7.091M |
| August 10, 2026 | 7.138M |
| August 07, 2026 | 7.573M |
| August 06, 2026 | 7.542M |
| August 05, 2026 | 7.481M |
| August 04, 2026 | 7.384M |
| August 03, 2026 | 7.318M |
| July 31, 2026 | 7.546M |
| July 30, 2026 | 7.585M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.415M |
| Regeneron Pharmaceuticals, Inc. | 720681.1 |
| Vertex Pharmaceuticals, Inc. | 1.013M |
| Amgen, Inc. | 2.956M |
| Biogen, Inc. | 1.014M |